Healthcare - Biotechnology - NASDAQ - US
$ 8.01
-7.29 %
$ 1.1 B
Market Cap
-2.12
P/E
Price Target
Average
191.30%
Revenue Forecast
Estimate
53.26%
EBIT
Estimate
26.44%
Net Income
Estimate
10.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vir Biotechnology, Inc.
Wall Street analysts predict an average 1-year price target for VIR of $23.3 , with forecasts ranging from a low of $15 to a high of $28 .
VIR Lowest Price Target
Wall Street Target
15 USD
87.27%
VIR Average Price Target
Wall Street Target
23.3 USD
191.30%
VIR Highest Price Target
Wall Street Target
28 USD
249.56%
REVENUE FORECAST
Revenue Forecast Chart VIR
EBIT FORECAST
EBIT Forecast Chart VIR
NET INCOME FORECAST
Net Income Chart VIR